157 related articles for article (PubMed ID: 23729807)
1. DcR3 mutations in patients with juvenile-onset systemic lupus erythematosus lead to enhanced lymphocyte proliferation.
Chokdeemeeboon C; Ammarinthnukrowh P; Tongkobpetch S; Srichomtong C; Deekajorndech T; Rianthavorn P; Kingwattanakul P; Avihingsanon Y; Wright HL; Akkahat P; Hoven VP; Mekboonsonglarp W; Edwards SW; Hirankarn N; Suphapeetiporn K; Shotelersuk V
J Rheumatol; 2013 Aug; 40(8):1316-26. PubMed ID: 23729807
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus.
Lee CS; Hu CY; Tsai HF; Wu CS; Hsieh SL; Liu LC; Hsu PN
Clin Exp Immunol; 2008 Mar; 151(3):383-90. PubMed ID: 18190609
[TBL] [Abstract][Full Text] [Related]
3. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
Han B; Moore PA; Wu J; Luo H
Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
[TBL] [Abstract][Full Text] [Related]
5. The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus.
Midgley A; McLaren Z; Moots RJ; Edwards SW; Beresford MW
Arthritis Rheum; 2009 Aug; 60(8):2390-401. PubMed ID: 19644848
[TBL] [Abstract][Full Text] [Related]
6. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
[TBL] [Abstract][Full Text] [Related]
7. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.
Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W
Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309
[TBL] [Abstract][Full Text] [Related]
8. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
[TBL] [Abstract][Full Text] [Related]
9. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis.
Bamias G; Kaltsa G; Siakavellas SI; Papaxoinis K; Zampeli E; Michopoulos S; Zouboulis-Vafiadis I; Ladas SD
Clin Immunol; 2010 Nov; 137(2):242-9. PubMed ID: 20675196
[TBL] [Abstract][Full Text] [Related]
10. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
Rianthavorn P; Chokedeemeeboon C; Deekajorndech T; Suphapeetiporn K
Lupus; 2013 Jun; 22(7):721-6. PubMed ID: 23640982
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.
Otsuki T; Tomokuni A; Sakaguchi H; Aikoh T; Matsuki T; Isozaki Y; Hyodoh F; Ueki H; Kusaka M; Kita S; Ueki A
Clin Exp Immunol; 2000 Feb; 119(2):323-7. PubMed ID: 10632670
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
[TBL] [Abstract][Full Text] [Related]
15. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
16. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
17. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
18. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
[TBL] [Abstract][Full Text] [Related]
19. Onset age affects mortality and renal outcome of female systemic lupus erythematosus patients: a nationwide population-based study in Taiwan.
Chen YM; Lin CH; Chen HH; Chang SN; Hsieh TY; Hung WT; Hsieh CW; Lai KL; Lan JL; Chen DY; Lan TH
Rheumatology (Oxford); 2014 Jan; 53(1):180-5. PubMed ID: 24136069
[TBL] [Abstract][Full Text] [Related]
20. Functional characterisation of decoy receptor 3 in Crohn's disease.
Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
